Literature DB >> 12354733

Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients.

Yoshie Ochiai1, Patrick M McCarthy, Nicholas G Smedira, Michael K Banbury, Jose L Navia, Jingyuan Feng, Amy P Hsu, Michael L Yeager, Tiffany Buda, Katherine J Hoercher, Michael W Howard, Masami Takagaki, Kazuyoshi Doi, Kiyotaka Fukamachi.   

Abstract

BACKGROUND: Insertion of an implantable left ventricular assist device (LVAD) complicated by early right ventricular (RV) failure has a poor prognosis and is largely unpredictable. Prediction of RV failure after LVAD placement would lead to more precise patient selection and optimal device selection. METHODS AND
RESULTS: We reviewed data from 245 patients (mean age, 54+/-11 years; 85% male) with 189 HeartMate (77%) and 56 Novacor (23%) LVADs. Ischemic cardiomyopathy predominated (65%), and 29% had dilated cardiomyopathy. Overall, RV assist device (RVAD) support was required after LVAD insertion for 23 patients (9%). We compared clinical and hemodynamic parameters before LVAD insertion between RVAD (n=23) and No-RVAD patients (n=222) to determine preoperative risk factors for severe RV failure. By univariate analysis, female gender, small body surface area, nonischemic etiology, preoperative mechanical ventilation, circulatory support before LVAD insertion, low mean and diastolic pulmonary artery pressures (PAPs), low RV stroke work (RVSW), and low RVSW index (RVSWI) were significantly associated with RVAD use. Elevated PAP and pulmonary vascular resistance were not risk factors. Risk factors by multivariable logistic regression were preoperative circulatory support (odds ratio [OR], 5.3), female gender (OR, 4.5), and nonischemic etiology (OR, 3.3).
CONCLUSIONS: The need for circulatory support, female gender, and nonischemic etiology were the most significant predictors for RVAD use after LVAD insertion. Regarding hemodynamics, low PAP and low RVSWI, reflecting low RV contractility, were important parameters. This information may lead to better patient selection for isolated LVAD implantation.

Entities:  

Mesh:

Year:  2002        PMID: 12354733

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  84 in total

1.  Decision tree for adjuvant right ventricular support in patients receiving a left ventricular assist device.

Authors:  Yajuan Wang; Marc A Simon; Pramod Bonde; Bronwyn U Harris; Jeffrey J Teuteberg; Robert L Kormos; James F Antaki
Journal:  J Heart Lung Transplant       Date:  2011-12-14       Impact factor: 10.247

2.  A case of late-onset right ventricular failure after implantation of a continuous-flow left ventricular assist device.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Taro Shiga; Miyoko Endo; Toshiro Inaba; Hisataka Maki; Masaru Hatano; Atsushi Yao; Takashi Nishimura; Yasunobu Hirata; Shunei Kyo; Minoru Ono; Ryozo Nagai
Journal:  J Artif Organs       Date:  2012-01-17       Impact factor: 1.731

Review 3.  Heart failure in women.

Authors:  J Julia Shin; Eman Hamad; Sandhya Murthy; Ileana L Piña
Journal:  Clin Cardiol       Date:  2012-03       Impact factor: 2.882

4.  Short and long term outcomes of 200 patients supported by continuous-flow left ventricular assist devices.

Authors:  Athanasios Tsiouris; Gaetano Paone; Hassan W Nemeh; Jamil Borgi; Celeste T Williams; David E Lanfear; Jeffrey A Morgan
Journal:  World J Cardiol       Date:  2015-11-26

Review 5.  Echocardiographic assessment for ventricular assist device placement.

Authors:  Antolin S Flores; Michael Essandoh; Gregory C Yerington; Amar M Bhatt; Manoj H Iyer; William Perez; Victor R Davila; Ravi S Tripathi; Katja Turner; Galina Dimitrova; Michael J Andritsos
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

6.  Initial in vivo evaluation of the DexAide right ventricular assist device.

Authors:  Yoshio Ootaki; Keiji Kamohara; Masatoshi Akiyama; Firas Zahr; Michael W Kopcak; Raymond Dessoffy; Alex Massiello; David Horvath; Ji-Feng Chen; Stephen Benefit; Leonard A R Golding; Kiyotaka Fukamachi
Journal:  ASAIO J       Date:  2005 Nov-Dec       Impact factor: 2.872

7.  Development of a small implantable right ventricular assist device.

Authors:  Kiyotaka Fukamachi; David J Horvath; Alex L Massiello; Yoshio Ootaki; Keiji Kamohara; Masatoshi Akiyama; Firas Zahr; Michael W Kopcak; Raymond Dessoffy; Ji-Feng Chen; Stephen Benefit; Leonard A R Golding
Journal:  ASAIO J       Date:  2005 Nov-Dec       Impact factor: 2.872

8.  Right ventricular pressure-volume loops using simultaneous radionuclide angiography with a multiwire gamma camera and right heart catheterization.

Authors:  Thein Htay; Deval Mehta; Liang Sun; Jeffrey Lacy; Raed Aqel; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2005 Jul-Aug       Impact factor: 5.952

9.  Approach to patients with heart failure and pulmonary hypertension.

Authors:  Paul R Forfia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

10.  Percutaneous Double Lumen Cannula for Right Ventricle Assist Device System: A Computational Fluid Dynamics Study.

Authors:  Francesca Condemi; Dongfang Wang; Gionata Fragomeni; Fuqian Yang; Guangfeng Zhao; Cameron Jones; Cherry Ballard-Croft; Joseph B Zwischenberger
Journal:  Biocybern Biomed Eng       Date:  2016-04-18       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.